↓ Skip to main content

Cochrane Database of Systematic Reviews

Brivaracetam add-on therapy for drug-resistant epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

blogs
1 blog
wikipedia
1 Wikipedia page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
10 Mendeley
Title
Brivaracetam add-on therapy for drug-resistant epilepsy
Published in
Cochrane database of systematic reviews, March 2022
DOI 10.1002/14651858.cd011501.pub3
Pubmed ID
Authors

Rebecca Bresnahan, Mariangela Panebianco, Anthony G Marson

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 30%
Student > Bachelor 2 20%
Unknown 5 50%
Readers by discipline Count As %
Psychology 2 20%
Medicine and Dentistry 2 20%
Unknown 6 60%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2022.
All research outputs
#3,449,535
of 21,360,407 outputs
Outputs from Cochrane database of systematic reviews
#5,967
of 12,052 outputs
Outputs of similar age
#66,794
of 336,219 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 19 outputs
Altmetric has tracked 21,360,407 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 336,219 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.